Clinical investigation of medicinal products in the treatment of chronic heart failure

  • Email
  • Help
Current effective version

Revision 2 - Adopted guideline

Revision 2 enters into effect 01/03/2018 - see below

Reference numberCPMP/EWP/235/95 Rev.2
Published20/09/2017
Effective from01/03/2018
KeywordsHeart failure, left ventricular function, mortality, morbidity, hospitalisation
DescriptionThis document provides guidance for the clinical investigation of medicinal products in the treatment of cardiac failure.


Document history

Revision 2 

Adopted guideline

 

 
Overview of comments
 

Draft guideline
 

Concept paper

Published: 20/09/2017
Effective from: 01/03/2018

 

Published: 26/09/2017
 

Published: 11/02/2016
 

Published: 01/03/2013

Revision 1

Current version

Adopted guidelineIn operation: 01/06/2000–01/03/2018


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more